Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 1.00 |
| ▸ | PLCG2 | P16885 | 1/20 | 0.67 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.67 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.67 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.67 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.67 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.67 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.67 |
| ▸ | LPAR6 | P43657 | 2/20 | 0.67 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.66 |
| ▸ | AKT1 | P31749 | 1/20 | 0.64 |
| ▸ | P2RY10 | O00398 | 6/20 | 0.63 |
| ▸ | GPR174 | Q9BXC1 | 6/20 | 0.63 |
| ▸ | GPR34 | Q9UPC5 | 3/20 | 0.63 |
| ▸ | CES2 | O00748 | 1/20 | 0.59 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.59 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.56 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31442571 | 1.00 | GPR55 (1.00) | GPR55PLCG2LPAR1LPAR4LPAR5 | |
| SCHEMBL31442358 | 1.00 | GPR55 (1.00) | GPR55PLCG2LPAR1LPAR4LPAR5 | |
| SCHEMBL31442360 | 1.00 | GPR55 (1.00) | GPR55PLCG2LPAR1LPAR4LPAR5 | |
| SCHEMBL31442341 | 1.00 | GPR55 (1.00) | GPR55PLCG2LPAR1LPAR4LPAR5 | |
| SCHEMBL19493039 | 1.00 | GPR55 (1.00) | GPR55PLCG2LPAR1LPAR4LPAR5 | |
| SCHEMBL20836054 | 1.00 | GPR55 (1.00) | GPR55PLCG2LPAR1LPAR4LPAR5 | |
| SCHEMBL31442333 | 1.00 | GPR55 (1.00) | GPR55PLCG2LPAR1LPAR4LPAR5 | |
| SCHEMBL31442340 | 1.00 | GPR55 (1.00) | GPR55PLCG2LPAR1LPAR4LPAR5 | |
| SCHEMBL17482442 | 1.00 | GPR55 (1.00) | GPR55PLCG2LPAR1LPAR4LPAR5 | |
| SCHEMBL31442478 | 1.00 | GPR55 (1.00) | GPR55PLCG2LPAR1LPAR4LPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210346277-A1 | Pharmaceutical Formulation | KLARIA PHARMA HOLDING AB (SE) | 2021-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210346277-A1 | Pharmaceutical Formulation | ALG1, CNR1, CNR2 | GPR55 461/4885PLCG2 658/4885LPAR1 148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.